BridgePoint nets CE Mark for CTO crossing, re-entry systems
BridgePoint Medical has received CE Mark for its coronary and peripheral chronic total occlusion (CTO) crossing system comprised of the CrossBoss CTO crossing catheter and the Stingray CTO re-entry system.
According to the Minneapolis-based company, the BridgePoint System is a series of interventional catheters that are designed to navigate diseased arteries, in preparation for blood flow restoration via angioplasty and stenting.
The disposable CrossBoss and the Stingray are indicated in the European Union for adults with coronary or peripheral artery disease, age 18 and older. The devices are contraindicated for use in cerebral vasculature.
According to the Minneapolis-based company, the BridgePoint System is a series of interventional catheters that are designed to navigate diseased arteries, in preparation for blood flow restoration via angioplasty and stenting.
The disposable CrossBoss and the Stingray are indicated in the European Union for adults with coronary or peripheral artery disease, age 18 and older. The devices are contraindicated for use in cerebral vasculature.